041960.KQ
Komipharm International Co., Ltd.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 9,380.00
+8.06%Year over year
Reported trailing growth
- Revenue
- -3.3%
- EBITDA
- -74.4%
- EBIT
- -71.0%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- -72.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +9.6%
- EBITDA
- +192.6%
- EBIT
- -98.6%
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026